Status:
COMPLETED
Do Low High Density Lipoprotein (HDL) Levels Predict Treatment Outcome in Patients With Chronic Hepatitis C Viral Infection?
Lead Sponsor:
Ziv Hospital
Collaborating Sponsors:
Hillel Yafe MC Hadera
Conditions:
Chronic Hepatitis C Viral Infection
Eligibility:
All Genders
18+ years
Brief Summary
The working hypothesis is that the low HDL serum level predict favorable response to anti viral treatment in chronic HCV (genotype 1) viral infection. This might be used to improve the rate of sustain...
Detailed Description
Lipoproteins are closely connected to the process of hepatitis C virus (HCV) infection. Metabolic syndrome predicts negative treatment outcome in HCV infection. Aim: to assess the association between...
Eligibility Criteria
Inclusion
- Chronic HCV genotype 1 naive patients
Exclusion
- Co infection with HBV, HIV, HDV
- Decompensated liver disease
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01159613
Start Date
April 1 2008
End Date
January 1 2009
Last Update
July 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziv medical center liver unit
Safed, Israel, Israel